Published on November 26, 2009 at 1:36 AM
Reportlinker.com announces that a new market research report is available in its catalogue: Cancer Therapies - Global Market Opportunities
http://www.reportlinker.com/p0164250/Cancer-Therapies---Global-Market-Opportunities.html
Cancer therapies are geared towards controlling the growth of cancerous tumors, and preventing the spread of cancer to other organs of the body. Cancer care is becoming a prime concern among national health authorities, in both developed and developing countries alike, leading to significant investments in developing and improving the healthcare system's screening systems, and abilities. Standard cancer treatments such as chemotherapy, radiation therapy, surgery, given their relatively higher side effects and disadvantages, will likely be brushed aside by new biotherapy and immunological treatments, which are expected to spruce up growth. The market for world cancer therapies continues to gain traction as companies explore advancements and improvements in drug delivery techniques translating to greater market opportunity.
Technological developments in proteomics sciences, genomics, and transcriptomics, and a better understanding of pathologies, have lowered the entry barriers in cancer therapy research. This has encouraged companies to invest in new research and development projects, and has paved the way for identifying and validating new therapeutic drugs, which were hitherto kept under the wraps. Developments in toxicity and preclinical studies, coupled with the development of high-throughput screening, oral delivery formulations, chemical synthesis, cancer vaccines and molecular libraries, and improvements in characterizing and producing biological molecules, make cancer therapies a promising market.
These and other market data and trends are presented in "Cancer Therapies: Global Market Opportunities" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.
SOURCE Reportlinker